Home ยป Deliberate Release

Deliberate Release

  • 20-08-2021

    Advice following the European consultation on the authorisation process of GMOs in medical applications

    The Ministry of Infrastructure and Water Management has asked COGEM whether an enviro...

    Advisory reports
    CGM/210820-01 View more
  • 24-03-2021

    Generic environmental risk assessment of clinical trials with MVA vectors

    The modified vaccinia virus Ankara (MVA) is a biologically contained virus with a his...

    Advisory reports
    CGM/210324-01 View more
  • 24-03-2021

    Generic environmental risk assessment of replication-deficient adenoviral vectors in clinical trials

    Vectors derived from adenoviruses (adenoviral (AdV) vectors) are the most commonly us...

    Advisory reports
    210324-02 View more
  • 11-12-2020

    Plant material inactivation

    In the Netherlands, there are no genetically modified (GM) crops authorised for culti...

    Advisory reports
    CGM 2020-05 View more
  • 10-10-2019

    No rose without thorns

    The current legislation on genetically modified (GM) crops in the European Union (EU)...

    Policy reports
    CGM/191010-01 View more
  • 17-12-2015

    Testing impacts of toxic compounds from transgenic crops on non-target arthropods in tier-1 studies: exposure and response

    The assessment of potential adverse effects on non-target organisms is an important c...

    Research reports
    CGM 2015-08 View more
  • 10-11-2014

    Research report Survey of Field trials with Genetically Modified Plants – Global trends and developments

    The COGEM has commissioned a research project to identify which field trials are perf...

    Research reports
    CGM 2014-04 View more
  • 26-09-2013

    Abstract of COGEM advisory reports on the application for a clinical trial testing recombinant Vaccinia virus- en Fowlpox virus- vaccine in patients with prostate cancer

    In the Netherlands recently an application was filed for a clinical trial entitled &#...

    Advisory reports
    CGM/130926-01 View more
  • 27-02-2013

    Criteria for the molecular characterisation of GMOs for medical and veterinary applications

    In recent years in the Netherlands clinical and veterinary studies involving genetica...

    Advisory reports
    CGM/130227-05 View more
  • 27-11-2012

    The use of statistical tools in field testing for effects of GM plants on non-target organisms (NTOs)

    Data to assess whether a GM crop could have an adverse effect on non-target organisms...

    Research reports
    CGM 2012-06 View more
  • 30-10-2012

    Gene therapy clinical trials: what about the environment? A comparison between the Netherlands and North America

    Gene therapy offers perspectives for the treatment of diseases that are difficult to ...

    Research reports
    CGM 2012-07 View more
  • 14-05-2012

    The possible role of honeybees in the spread of pollen from field trials

    Honey bees are important pollinators in agricultural crops, home gardens, orchards an...

    Research reports
    CGM 2012-02 View more